Your browser is no longer supported. Please, upgrade your browser.
Settings
GLQ Clough Global Equity Fund daily Stock Chart
GLQ [NYSE]
Clough Global Equity Fund
Index- P/E- EPS (ttm)-2.15 Insider Own- Shs Outstand- Perf Week0.32%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month6.14%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter16.64%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.55 Perf Half Y11.01%
Book/sh12.99 P/B0.92 EPS next Y- ROA- Target Price- Perf Year29.27%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.00 - 12.04 Perf YTD9.57%
Dividend- P/FCF- EPS past 5Y0.00% ROI- 52W High-0.42% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low33.24% ATR0.08
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)86.22 Volatility0.55% 0.65%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.43 Prev Close11.96
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume114.86K Price11.99
Recom- SMA202.39% SMA506.39% SMA20013.26% Volume49,686 Change0.25%
Feb-06-17 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Jan-31-17 10:00AM  Clough Global Equity Fund Business Wire
Jan-30-17 02:16PM  Saba Capital Management Invests in Clough Global Equity Fund
Jan-25-17 04:43PM  Clough Global Closed End Funds Portfolio Manager Departure Business Wire
Dec-30-16 10:00AM  Clough Global Equity Fund Business Wire
Dec-15-16 01:04PM  CLOUGH GLOBAL EQUITY FUND Financials
Dec-14-16 09:00AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Nov-30-16 10:00AM  Clough Global Equity Fund Business Wire
Nov-07-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Oct-31-16 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-31-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-08-16 09:30AM  Clough Global Equity Fund Announces Fund Distribution Rate Change and Declares Monthly Cash Distribution Business Wire
Jul-29-16 10:00AM  Clough Global Equity Fund Business Wire
Jun-30-16 10:00AM  Clough Global Equity Fund Business Wire
May-31-16 10:00AM  Clough Global Equity Fund Business Wire
May-06-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-29-16 09:30AM  Clough Global Equity Fund Business Wire
Mar-31-16 09:35AM  Clough Global Equity Fund Business Wire
Mar-09-16 09:30AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Feb-29-16 09:35AM  Clough Global Equity Fund Business Wire
Feb-08-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jan-29-16 09:30AM  Clough Global Equity Fund Business Wire
Dec-31-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-30-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Oct-30-15 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-15 09:35AM  Clough Global Equity Fund Business Wire
Aug-31-15 09:30AM  Clough Global Equity Fund Business Wire
Aug-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jul-31-15 09:35AM  Clough Global Equity Fund Business Wire
Jul-29-15 04:00PM  Clough Global Equity Fund Announces Voting Results from 2015 Annual Shareholder Meeting Business Wire
Jul-07-15 05:10PM  Clough Global Equity Fund Announces Annual Shareholder Meeting Business Wire
Jun-30-15 09:35AM  Clough Global Equity Fund Business Wire
May-29-15 09:30AM  Clough Global Equity Fund Business Wire
May-11-15 04:00PM  Clough Global Closed-End Funds Approve Participation Agreement Permitting Increased Share Purchases by RiverNorth Funds Business Wire
May-08-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-30-15 09:30AM  Clough Global Equity Fund Business Wire
Apr-20-15 04:00PM  Clough Global Closed-End Funds Adopt Share Repurchase Programs Business Wire
Mar-31-15 10:00AM  Clough Global Equity Fund Business Wire
Feb-27-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-30-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-05-15 09:30AM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Dec-31-14 09:30AM  Clough Global Equity Fund Business Wire
Dec-11-14 04:15PM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Nov-26-14 10:00AM  Clough Global Equity Fund Business Wire
Oct-31-14 09:30AM  Clough Global Equity Fund Business Wire
Oct-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Sep-30-14 09:30AM  Clough Global Equity Fund Business Wire
Sep-12-14 09:30AM  Clough Global Equity Fund Announces Change to Fiscal Year End Business Wire
Aug-29-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-31-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-15-14 10:05AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: GLQ, HIO, ISD at TheStreet
Jul-08-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Jun-30-14 09:30AM  Clough Global Equity Fund Business Wire
Jun-13-14 10:00AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GLQ, AIF, TCPC at TheStreet
Jun-01-14 05:49AM  How I Made 7% Retirement Income Investing In CEFs at Seeking Alpha
May-30-14 09:30AM  Clough Global Equity Fund Business Wire
May-13-14 10:05AM  3 Stocks With Upcoming Ex-Dividend Dates: GLQ, BGCP, CNW at TheStreet
Apr-30-14 09:30AM  Clough Global Equity Fund Business Wire
Apr-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Mar-31-14 10:00AM  Clough Global Equity Fund Business Wire
Mar-13-14 10:00AM  Dividend Watch: 3 Stocks Going Ex-Dividend Friday: GLQ, DHY, PHD at TheStreet
Feb-28-14 09:30AM  Clough Global Equity Fund Business Wire
Feb-11-14 10:03AM  Tomorrow's Ex-Dividends To Watch: GLQ, MEN, MYD, BKH, AMP at TheStreet
Jan-31-14 09:00AM  Clough Global Equity Fund Business Wire
Jan-15-14 09:30AM  Clough Global Equity Fund Business Wire
Jan-14-14 10:00AM  Tomorrow's Ex-Dividends To Watch: GLQ, GNT, LDP, PKI, GMCR at TheStreet
Jan-06-14 10:00AM  3 With Upcoming Ex-Dividend Dates: GLQ, BSBR, NTAP at TheStreet
Dec-19-13 02:16PM  Clough Global Equity Fund Declares Final Quarterly Cash Distribution of $0.29 Per Share before Moving to New Monthly Distributions Business Wire
Dec-12-13 06:30AM  Clough Global Equity Fund Announces an Annual Increase in Cash Distribution Per Common Share and Changes Distribution Payments to Monthly Business Wire
Nov-26-13 01:27PM  How I Made 7% Income While Lowering Risk at Seeking Alpha
Oct-31-13 09:45AM  Clough Global Equity Fund Business Wire
Oct-09-13 03:02PM  Clough Global Equity Fund Revises Quarterly Cash Distribution Ex-Date and Record Date Business Wire
Oct-08-13 06:30AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-31-13 09:00AM  Clough Global Equity Fund Business Wire
Jul-25-13 03:59AM  The CEF Firecracker at Seeking Alpha
Jul-24-13 09:28AM  A High Income, Lower Risk CEF Portfolio For Retirees at Seeking Alpha
Jul-09-13 06:01PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Apr-30-13 07:00AM  Clough Global Equity Fund Business Wire
Apr-16-13 10:00AM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Appointment of Vincent W. Versaci to the Board of Trustees Business Wire
Apr-02-13 12:27PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-31-13 05:32PM  Clough Global Equity Fund Business Wire
Jan-08-13 11:47AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Oct-05-12 02:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Sep-28-12 01:32PM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Resignation of Andrew C. Boynton Business Wire
Jul-03-12 09:32AM  A Diversified Approach To International Dividends at Seeking Alpha
Apr-03-12 01:16PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-23-12 07:27AM  Dividend Champs With Yields As High As 11.2% at Seeking Alpha
Jan-10-12 12:41PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-09-12 10:44AM  CEF Weekly Review: Convertibles Shine at Seeking Alpha
Dec-14-11 01:41PM  Clough Capital: 3 Interesting Closed-End Funds Are Quasi Hedge Funds at Seeking Alpha
Oct-28-11 12:00AM  Portfolio Insights by Brett Arends: Turmoil leaves closed-end funds on sale at MarketWatch
Oct-05-11 01:06PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-07-11 03:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Apr-06-11 12:03PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-24-11 03:32PM  Growth Story In China Shifts Focus To Internal Consumer Driven Demand: Exclusive Interview From Eric A. Brock Of Clough Capital Partners Wall Street Transcript
Jan-10-11 03:20PM  [video] Daily Dividend Report: GG, AYI, GLO, GLQ, MVO at Forbes.com
Jan-07-11 04:18PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Sep-29-10 12:48PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Clough Global Equity Fund is a close ended equity mutual fund launched and managed by Clough Capital Partners, L.P. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental and quantitative analysis with a bottom up stock picking approach to create its portfolio, with focus on factors such as a company's competitive position, quality of company management, quality and visibility of earnings and cash flow, balance sheet strength, and relative valuation. The fund follows a theme-based investment process which involves focusing on such events as industry consolidation, technological change, an emerging shortage of a product or raw material, and changes in government regulations. It benchmarks the performance of its portfolio against the S&P 500 Index. Clough Global Equity Fund was formed on January 25, 2005 and is domiciled in the United States.
SCMP Sucampo Pharmaceuticals, Inc. daily Stock Chart
SCMP [NASD]
Sucampo Pharmaceuticals, Inc.
Index- P/E42.28 EPS (ttm)0.30 Insider Own54.19% Shs Outstand45.64M Perf Week9.57%
Market Cap575.06M Forward P/E7.50 EPS next Y1.68 Insider Trans-1.48% Shs Float26.11M Perf Month10.53%
Income13.40M PEG3.02 EPS next Q0.48 Inst Own55.50% Short Float26.47% Perf Quarter-18.08%
Sales212.40M P/S2.71 EPS this Y147.70% Inst Trans32.99% Short Ratio6.47 Perf Half Y11.41%
Book/sh3.38 P/B3.73 EPS next Y38.16% ROA2.90% Target Price17.33 Perf Year-4.26%
Cash/sh- P/C- EPS next 5Y14.00% ROE11.70% 52W Range9.59 - 17.55 Perf YTD-7.01%
Dividend- P/FCF26.26 EPS past 5Y67.30% ROI10.10% 52W High-28.21% Beta1.37
Dividend %- Quick Ratio3.20 Sales past 5Y19.90% Gross Margin63.60% 52W Low31.39% ATR0.51
Employees159 Current Ratio3.60 Sales Q/Q73.40% Oper. Margin15.10% RSI (14)61.78 Volatility3.74% 4.26%
OptionableYes Debt/Eq1.51 EPS Q/Q19.20% Profit Margin6.30% Rel Volume2.24 Prev Close11.80
ShortableYes LT Debt/Eq1.36 EarningsMar 07 BMO Payout0.00% Avg Volume1.07M Price12.60
Recom2.30 SMA2010.84% SMA50-1.61% SMA2001.78% Volume2,393,517 Change6.78%
Dec-22-16Upgrade Mizuho Neutral → Buy $16
Nov-15-16Reiterated Maxim Group Buy $17 → $19
Nov-14-16Reiterated Mizuho Neutral $13 → $16
Sep-07-16Initiated Northland Capital Outperform
Aug-04-16Downgrade Mizuho Buy → Neutral $13
Aug-01-16Reiterated Maxim Group Buy $26 → $17
May-05-16Upgrade WallachBeth Hold → Buy $16
Apr-20-16Upgrade Mizuho Neutral → Buy $14
Mar-10-16Reiterated WallachBeth Hold $27 → $16
Mar-09-16Reiterated Maxim Group Buy $25 → $26
Jan-15-16Reiterated Mizuho Neutral $19 → $14
Nov-20-15Initiated Jefferies Hold $19
Nov-13-15Reiterated Mizuho Neutral $22 → $19
Oct-29-15Resumed ROTH Capital Buy $29
Oct-09-15Initiated Mizuho Neutral
Sep-03-15Initiated Leerink Partners Mkt Perform
Aug-27-15Reiterated WallachBeth Hold $24 → $27
Aug-27-15Reiterated H.C. Wainwright Buy $31 → $36
Aug-24-15Initiated H.C. Wainwright Buy $31
Aug-06-15Reiterated WallachBeth Hold $19 → $24
Feb-17-17 05:41PM  Sucampo Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire
02:04PM  Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb-16-17 04:25PM  Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb-09-17 10:36AM  Glaxo (GSK) Beats on Q4 Earnings, Posts Dismal '17 View
06:30AM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference GlobeNewswire
Feb-07-17 10:56AM  Mallinckrodt (MNK) Tops on Earnings in Transition Quarter
Feb-06-17 08:19AM  Portola, HealthCare Royalty Partners Ink $150 Million Deal
Feb-03-17 08:06AM  AMAG Down Despite Positive Data on Makena Auto-Injector
Feb-02-17 09:49AM  Novartis (NVS) Votubia Gets EU Approval for Label Expansion
07:21AM  Catabasis Hits 52-Week Low on Poor DMD Drug Study Data
Jan-31-17 10:45AM  Mylan (MYL) Gets Favorable Verdict for Copaxone in the US
Jan-30-17 04:19PM  Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised)
10:20AM  Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid
Jan-27-17 02:42PM  AbbVie (ABBV) Q4 Earnings Meet Estimates, Revenues Lag
09:05AM  Endo (ENDP) Restructures its Branded Pharmaceutical Unit
Jan-26-17 03:29PM  Celgene (CELG) Misses on Earnings & Revenues, Keeps View
Jan-23-17 05:26PM  Gilead (GILD) HCV Therapy Application Validated in Europe
05:22PM  Bristol-Myers Settles Litigation with Merck for Keytruda
08:28AM  Prima Biomed Initiates Randomized Study for Breast Cancer
Jan-19-17 09:04AM  Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan-18-17 08:29AM  Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo
08:26AM  Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Jan-17-17 09:30AM  Zacks.com featured highlights: Glaukos, Daqo New Energy, Calavo Growers and Sucampo Pharmaceuticals -5.60%
08:28AM  Key FDA Events to Watch Out for in Q1
Jan-16-17 08:16AM  4 Profitable Stocks with Amazingly High Returns
08:09AM  5 Top Ranked Stocks with Upgraded Broker Ratings to Buy Now
Jan-13-17 09:55AM  Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan-12-17 04:19PM  TherapeuticsMD's Rejoice Study Data Published in Journal
08:43AM  Merck KGaA, Vertex Announce Tie-Up for Oncology Programs
Jan-11-17 04:42PM  Valeant Streamlines Portfolio with Skincare Brands Sale
09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Insulet, Western Refining, PennyMac Mortgage Investment Trust and Extended Stay America
08:27AM  Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan-10-17 06:03PM  5 Underperformers of 2016: Turnaround Story in 2017?
09:30AM  Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucows and E*TRADE Financial
Jan-09-17 08:23AM  Go Driehaus Way: 5 Momentum Picks
07:32AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-06-17 10:18AM  Top Ranked Growth Stocks to Buy for January 6th
Jan-04-17 09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
08:51AM  Why Sucampo Pharmaceuticals (SCMP)Could Be an Impressive Growth Stock
Jan-03-17 08:32AM  3 Overlooked Drug Stocks to Watch Out for in 2017
Dec-29-16 09:30AM  Zacks.com featured highlights: Calavo Growers, Cytokinetics, Sucampo Pharmaceuticals, State National and CryoLife
Dec-28-16 07:37AM  5 Profitable Stocks to Buy for Great Returns
Dec-27-16 04:17PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
09:07AM  Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up
07:11AM  4 Top Stocks with Earnings Acceleration to Buy in 2017
Dec-23-16 11:22AM  Trump, Interest Rates And Biotech Investing In 2017 at Forbes
08:35AM  Ironwood, Allergan Report Positive Linzess IBS-C Study Data
Dec-22-16 01:19PM  Sucampo Pharmaceuticals, Inc. (SCMP) Announces Its New Debt Offering Of Convertible Notes at Insider Monkey
09:43AM  Sucampo Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCMP) : December 22, 2016
06:14AM  Sucampo Pharma upgraded by Mizuho
Dec-21-16 04:15PM  Stock Indexes Calm; Southwestern Energy Up 6%
07:32AM  Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : December 21, 2016
02:00AM  Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021 GlobeNewswire
Dec-20-16 05:40PM  Why NeoPhotonics, Sucampo Pharmaceuticals, and Worthington Industries Slumped Today at Motley Fool -20.48%
02:50PM  Here's Why Sucampo Pharmaceuticals Is Down Over 20% Today at Motley Fool
01:36PM  Dow Flirts With 20,000 As Caterpillar, Goldman Sachs, Nike Score Gains
Dec-19-16 04:06PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.03%
04:01PM  Sucampo Announces Proposed Convertible Senior Note Offering GlobeNewswire
01:47PM  Big-Cap Tech Names, Biotechs, Oils Lifting Market
08:47AM  Agios Stops Development of PKR Activator AG-519, Stock Falls
Dec-16-16 08:17AM  Roche (RHHBY) to Terminate Pacifica Bioscience Agreement
Dec-15-16 06:27AM  athenahealth (ATHN) Reaffirms 2016 View, Guides for 2017
Dec-14-16 09:17AM  Envision Healthcare Acquires Desert Mountain Consultants
08:09AM  Eli Lilly (LLY) to Offer Discount on Insulin from January
07:58AM  Kite Pharma Enters into Partnership with Vitruvian Networks
07:39AM  Proteon Slips to 52-Week Low on Kidney Disease Study Data
Dec-13-16 02:04PM  Top 10 Stocks Under $20
11:10AM  Stocks Stay Higher Ahead Of Fed; Dow Starts Eyeing 20,000
Dec-08-16 10:08AM  Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK
09:30AM  Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, Citrix Systems, VMware and Sanchez Energy
09:00AM  Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs
Dec-07-16 10:01AM  5 Stocks to Buy for Remarkable Earnings Growth in 2017 -5.51%
09:30AM  The Zacks Analyst Blog Highlights: Health Insurance Innovations, Aegean Marine Petroleum Network, KVH Industries, Sucampo Pharmaceuticals and Willdan Group
09:07AM  Sage Therapeutics Stock Up on SAGE-547 Regulatory Update
09:00AM  Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
08:55AM  Theravance Stock Up on Fast Track Status for Velusetrag
Dec-06-16 10:21AM  5 Best Small-Cap Stocks for 2017
08:24AM  GW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
Dec-05-16 03:21PM  Is Sucampo Pharmaceuticals, Inc. (SCMP) A Good Stock To Buy? at Insider Monkey
Dec-01-16 10:23AM  Heat Biologics Stock Falls on Negative Bladder Cancer Data
08:25AM  Achaogen (AKAO) Catches Eye: Stock Adds 6.5% in Session
Nov-30-16 05:22PM  Cytori Scleroderma Study Two-Year Follow-Up Data Published -5.25%
09:53AM  PhaseRx Soars on Orphan Drug Status for Rare Liver Disease
09:30AM  Zacks.com featured highlights: Chimera Investment, PennyMac Financial Services and Sucampo Pharmaceuticals
08:35AM  Sucampo (SCMP) Worth a Look: Stock Jumps 6.2% in Session
Nov-29-16 10:47AM  The Pockets of Speculative Action Have Dried Up +6.19%
08:25AM  Recro Pharma (REPH) in Focus: Stock Moves 19.8% Higher
Nov-28-16 03:12PM  Stocks Stay Red As Gold, Oil Prices Rise; Amazon, Building Stocks Weigh
12:15PM  Trump-Tied Plays Dip; Under Armour Up On Ticker Switch
05:01AM  How the founders of BET, Sucampo are changing the investment game for women-led companies at bizjournals.com
Nov-25-16 04:45PM  What You Need To Know For Your Week: Top 3 Earnings On Tap
01:11PM  Stocks End Thanksgiving Week With Modest Gains; Oil Slumps 3%
08:40AM  Looking for a Growth Stock? Why it is Time to Focus on Sucampo Pharmaceuticals (SCMP)
Nov-24-16 08:11AM  Glaxo Nucala Favorable in Rare Vasculitis Disease Study
Nov-23-16 08:30AM  Why Sucampo Pharmaceuticals (SCMP) Could Be Positioned for a Surge
08:18AM  Oragenics Jumps on Fast Track Status for Oral Mucositis Drug
07:38AM  Bristol-Myers' Opdivo Gets EU Approval for Label Expansion
Nov-22-16 09:30AM  Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, VMware and Alexandria Real Estate Equities
Nov-21-16 09:27AM  4 Stocks to Buy on Solid Earnings Acceleration
Nov-18-16 11:04AM  Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research and development of proprietary drugs for the treatment of gastrointestinal, ophthalmic, autoimmune, and oncology-based inflammatory disorders in the United States, Japan, Switzerland, and internationally. The company's marketed product includes AMITIZA, a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation in adults; irritable bowel syndrome with constipation in adult women; opioid-induced constipation in patients with chronic non-cancer pain; chronic constipation; and pediatric functional constipation. Its product candidates, which are in clinical development stage comprise Cobiprostone that is in Phase IIa trials for the treatment of oral mucositis, non-erosive reflux, and symptomatic gastroesophageal reflux diseases; RTU-1096, which has completed Phase I trial for treating inflammation/immune-related disorders; and RTU-009 that is in development stage for inflammation/immune-related disorders, as well as CPP-1X/sulindac combination product, which is in phase III clinical trial for the treatment of familial adenomatous polyposis. Sucampo Pharmaceuticals, Inc. was founded in 1996 is headquartered in Rockville, Maryland. Sucampo Pharmaceuticals, Inc. is a subsidiary of S&R Technology Holdings, LLC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Getman Daniel PDirectorNov 29Option Exercise6.803,79925,8333,799Nov 30 04:01 PM
Greenleaf PeterCEONov 29Option Exercise6.7582,459556,59884,972Nov 30 04:01 PM
Greenleaf PeterCEONov 29Sale16.7582,4591,381,1882,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 29Sale16.753,79963,6330Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Option Exercise6.8016,201110,16716,201Nov 30 04:01 PM
Greenleaf PeterCEONov 28Option Exercise6.75117,541793,402120,054Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Option Exercise8.3324,975208,04228,424Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Sale16.7324,975417,8323,449Nov 28 09:30 PM
Greenleaf PeterCEONov 28Sale16.91117,5411,987,6182,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Sale16.8916,201273,6350Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Option Exercise8.3399,025824,878102,474Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Sale15.8899,0251,572,5173,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Option Exercise8.3326,000216,58029,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Sale15.7726,000410,0203,449Nov 28 09:30 PM
Smith Andrew PChief Financial OfficerNov 15Sale15.581,76627,514348Nov 16 04:01 PM
CS Credit Suisse Group AG daily Stock Chart
CS [NYSE]
Credit Suisse Group AG
Index- P/E- EPS (ttm)-1.17 Insider Own3.10% Shs Outstand2.04B Perf Week4.52%
Market Cap31.64B Forward P/E9.80 EPS next Y1.58 Insider Trans0.00% Shs Float1.93B Perf Month0.13%
Income-2449.60M PEG- EPS next Q- Inst Own3.40% Short Float0.23% Perf Quarter9.09%
Sales17.44B P/S1.82 EPS this Y31.30% Inst Trans40.32% Short Ratio0.83 Perf Half Y29.76%
Book/sh20.13 P/B0.77 EPS next Y44.69% ROA-0.30% Target Price17.35 Perf Year22.25%
Cash/sh210.45 P/C0.07 EPS next 5Y0.30% ROE-5.50% 52W Range10.01 - 16.17 Perf YTD8.18%
Dividend0.72 P/FCF- EPS past 5Y-23.90% ROI2.90% 52W High-4.27% Beta1.57
Dividend %4.65% Quick Ratio- Sales past 5Y-5.50% Gross Margin- 52W Low54.65% ATR0.34
Employees47690 Current Ratio- Sales Q/Q-15.80% Oper. Margin42.10% RSI (14)54.60 Volatility1.58% 1.44%
OptionableYes Debt/Eq4.58 EPS Q/Q62.90% Profit Margin-14.00% Rel Volume0.79 Prev Close15.42
ShortableYes LT Debt/Eq4.58 EarningsFeb 14 BMO Payout- Avg Volume5.43M Price15.48
Recom2.00 SMA202.10% SMA501.53% SMA20015.50% Volume4,297,551 Change0.39%
Feb-17-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-13-17Downgrade Macquarie Neutral → Underperform
Nov-14-16Upgrade BofA/Merrill Neutral → Buy
Nov-10-16Upgrade Keefe Bruyette Mkt Perform → Outperform
Nov-04-16Downgrade Macquarie Outperform → Neutral
Jun-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform
Jun-27-16Downgrade JP Morgan Neutral → Underweight
Jun-13-16Downgrade Keefe Bruyette Outperform → Mkt Perform
May-20-16Upgrade BofA/Merrill Underperform → Neutral
Apr-05-16Downgrade Exane BNP Paribas Neutral → Underperform
Feb-23-16Upgrade Macquarie Underperform → Outperform
Feb-16-16Downgrade JP Morgan Overweight → Neutral
Feb-05-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-01-15Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-06-15Downgrade RBC Capital Mkts Outperform → Sector Perform $26
Feb-08-13Reiterated RBC Capital Mkts Outperform $27 → $30
Jan-05-10Initiated Barclays Capital Equal Weight
Nov-02-09Upgrade Citigroup Hold → Buy
Aug-20-09Upgrade FBR Capital Underperform → Mkt Perform
Jul-28-09Downgrade FBR Capital Mkt Perform → Underperform
Feb-21-17 04:11PM  Credit Suisse Offers Brighter Outlook on Europe at Investopedia
12:36AM  [$$] Whats Lurking in Credit Suisses Fat Margins at The Wall Street Journal
Feb-20-17 06:01PM  Credit Suisse Returns to Its Roots in Europe
05:52AM  [$$] What's Lurking in Credit Suisse's Fat Margins at The Wall Street Journal
Feb-17-17 05:32PM  Moody's assigns rating to a new structured note issued by Mortgage Repurchase Agreement Financing Trust, Series 2016-1 at Moody's
11:17AM  Credit Suisse Group AG :CS-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017
07:22AM  Credit Suisse upgraded by Morgan Stanley
Feb-16-17 09:37AM  Credit Suisse Group AG :CS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 16, 2017
Feb-15-17 02:49PM  5 China Stocks to Buy as Red Dragon Outshines Asia
09:16AM  Credit Suisse (CS) Reports Loss in Q4 on DOJ Settlement
06:00AM  Why For-Profit Colleges Could Thrive Under Trump at Investopedia
04:29AM  Credit Suisse Boosts Senior Asia Banker Pay by Up to 15% at Bloomberg
Feb-14-17 09:42PM  Credit Suisse Keeps Losing Money, Plans More Layoffs at Investopedia
05:12PM  Credit Suisse announces more layoffs; RTP impact unclear at bizjournals.com
12:23PM  Credit Suisse CEO Thiam on Cost Cuts, Volatility, Brexit
12:23PM  European stocks eke out a gain after GDP miss, keep win streak intact at MarketWatch
11:39AM  Credit Suisse Posts Loss, but Investors Eye Its 2017 Start at The Wall Street Journal
10:51AM  Credit Suisse Posts Loss Amid Justice Department Settlement at TheStreet
10:26AM  Finding Positives in Credit Suisse's 4Q Results
09:38AM  Stocks Move Lower Ahead of Yellen Testimony
09:32AM  Credit Suisse reports 4Q loss
09:28AM  [$$] Credit Suisse's Universally Bad Idea at The Wall Street Journal
09:15AM  Credit Suisse's Vexing Earnings Changes at The Wall Street Journal
08:57AM  Credit Suisse flags 6,500 job cuts in 2017 after $2.4 billion loss Reuters
08:23AM  Credit Suisse FX Strategist Watches for Disruptive Brexit
07:34AM  This Is What Caused Credit Suisse Shares to Open With a Bang on Tuesday
07:10AM  Credit Suisse Stock Rises on Revenue Growth at TheStreet
05:59AM  Credit Suisse Needs More Trump Bumps at Bloomberg
05:55AM  Is Credit Suisse on the Path to Recovery?
03:50AM  [$$] Credit Suisse changes tack on Swiss IPO amid stronger capital at Financial Times
03:03AM  Credit Suisse Posts Loss on DoJ Fine
02:14AM  Credit Suisse CEO Thiam Says Climate Is Better for Banks
01:15AM  Credit Suisse Plans to Cut Up to 6,500 Jobs This Year After Loss at Bloomberg
Feb-13-17 05:10PM  Credit Suisse 2016 net loss of 2.4 bn Swiss francs AFP
11:32AM  [$$] Listing of Credit Suisse's domestic operations facing opposition at Financial Times
Feb-09-17 10:01AM  Moody's ABCP rating activity ending February 3, 2017 at Moody's
09:20AM  Commodities Slightly Increased Amid Uncertainty PR Newswire
Feb-08-17 09:06AM  Do Distressed Valuations Mean Its a Good Time to Buy Deutsche Bank?
Feb-06-17 04:30PM  Credit Suisse Group AG -- Moody's assigns Ba2(hyb) rating to Credit Suisse Group AG's high-trigger AT1 capital securities at Moody's
03:42PM  Here's Your Sell-Side Conference Preview
08:30AM  Credit Suisse Announces Coupon Payments and Expected Coupon Payments on Credit Suisse X-Links Exchange Traded Notes (the "ETNs") PR Newswire
07:41AM  Credit Suisse Could Forgo Swiss IPO to Sell Own Stock: UBS at Bloomberg
Feb-03-17 09:07AM  What to Expect from Danahers Future Earnings
Feb-02-17 11:30AM  Market Has Been in Grip of Reflation Trade: O'Sullivan
Jan-31-17 06:39PM  Moody's assigns A1 (sf) rating to Alpine Term Notes Issued by Alpine Securitization LTD at Moody's
12:46PM  MOVES-Goldman leveraged finance banker DeFusco to join Credit Suisse Reuters
Jan-27-17 10:05AM  Trump's Policy Boost for U.S. Energy Industry
Jan-26-17 02:38PM  Jilting Jefferies Said to Cost Credit Suisse Bankers $10 Million at Bloomberg
02:38PM  Bankers Who Jilted Jefferies Said Facing $10 Million Breakup Fee
12:57PM  5 Best Stocks To Buy Now at Insider Monkey
08:20AM  Why now may be the time to buy China stocks at MarketWatch
Jan-25-17 07:00PM  Credit Suisse Said to Mull Dublin Expansion as Brexit Nears at Bloomberg
07:54AM  Sweeney: U.S. Can't Move Above 3% Blended Inflation
07:19AM  Sweeney: Tech, Not Trade, Hurt U.S. Manufacturing
06:59AM  Sweeney: U.S. Protectionism a Major Shift for the World
06:50AM  Sweeney: Inflation Scare, Not High Inflation in Next Year
Jan-23-17 12:35PM  Credit Suisse gets new head of commercial real estate finance Reuters
Jan-19-17 11:51PM  AP Top Extended Financial Headlines at 11:51 p.m. EST
03:44AM  [video]European Stocks Mixed, Banks Gain Ahead of ECB Rate Decision
Jan-18-17 03:36PM  Credit Suisse to pay $5.3B over mortgage-backed securities
02:36PM  Credit Suisse finalizes $5.3 billion mortgage deal with U.S. Reuters
12:51PM  Credit Suisse Resolves U.S. Mortgage Probe for $5.3 Billion
12:40PM  Credit Suisse finalizes $5.3 billion DOJ settlement over mortgage claims at MarketWatch
11:59AM  Credit Suisse Completes $5.3 Billion U.S. Deal Over Toxic Debt at Bloomberg
11:53AM  Credit Suisse finalizes $5.3 bln mortgage deal with U.S. Reuters
Jan-17-17 01:41PM  [$$] Flurry of DoJ settlements caps Obama administration's reign at Financial Times
06:00AM  How ETFs Are Dominating the Stock Market at Investopedia
04:56AM  Thiam: DOJ Settlement Was 'Biggest Cloud' Over Shares
02:54AM  Moody's assigns (P)A1 (sf) to Credit Suisse's proposed equity index linked notes at Moody's
Jan-14-17 09:52AM  Moodys to pay $864 mln to settle claims tied to housing-market collapse at MarketWatch
Jan-13-17 10:35AM  Top Ranked Income Stocks to Buy for January 13th
Jan-12-17 09:25AM  Commodities Gained Due to Higher Energy and Growth Expectations PR Newswire
Jan-07-17 12:01AM  [$$] Credit Suisse Shares Could Gain 13% at Barrons.com
Jan-06-17 01:37PM  These Are The 10 Best Cities To Work If You're A CFA
07:53AM  Credit Suisse May Not Need IPO to Bulk Up Buffers, Herro Says
Jan-05-17 08:30AM  Credit Suisse Announces Coupon Payments and Expected Coupon Payments on Credit Suisse X-Links Exchange Traded Notes (the "ETNs") PR Newswire
08:30AM  Credit Suisse Announces Coupon Amount on its Credit Suisse S&P MLP Index ETN (ticker symbol "MLPO"). PR Newswire
Jan-04-17 01:00PM  MOVES-Credit Suisse blocks attempt by Jefferies to lure senior bankers Reuters
10:26AM  Credit Suisse Moves to Block Jefferies Bid to Hire Bankers at Bloomberg
Jan-03-17 03:10PM  MOVES-Jefferies hires four senior Credit Suisse loan team members +6.64%
Dec-30-16 11:54AM  2016: European Banks Year in Review
Dec-29-16 12:00PM  European stocks break 3-day winning run, deepen losses for 2016 at MarketWatch
04:08AM  SEC probes Mozambique debt sold by Credit Suisse, BNP Paribas AFP
Dec-28-16 02:50PM  SEC investigates banks that sold Mozambique's "tuna bond" - WSJ Reuters
08:03AM  Credit Suisse Ratings Affirmed by Moody's; Outlook Stable
Dec-27-16 05:14PM  Credit Suisse AG -- Moody's Affirms A1 Debt and Deposit Ratings of Credit Suisse AG. Outlook Stable at Moody's
09:11AM  Deutsche Bank, Credit Suisse Settle With DOJ
08:17AM  Here's an European Bank That Actually Looks Promising
Dec-26-16 04:02PM  [$$] Market Talk: Daily Analysis Roundup at The Wall Street Journal
Dec-24-16 08:28PM  Credit Suisse, Deutsche Bank to Pay Billions to Settle Subprime Lending Charges
12:11AM  [$$] Art of the Deal: Barclays Takes Mortgage Fight to Court at The Wall Street Journal
12:10AM  [$$] Push to Resolve Toxic Securities Cases Yields Two Big Settlements, One Lawsuit at The Wall Street Journal
Dec-23-16 04:57PM  Is Deutsche Bank in the Clear After Settling With DOJ?
04:30PM  Deutsche's U.S. Mortgage Settlement to Cost Half the $14B Wall Street Feared
04:21PM  Dow Stalls Again in Quest for 20,000 in Quiet Pre-Christmas Trading
03:28PM  [$$] Push to Resolve Toxic-Securities Cases Yields Settlements and Lawsuit at The Wall Street Journal
01:06PM  Deutsche Bank Settles, While Barclays Braces for a Fight
12:26PM  A Sudden Burst of Activity on Mortgage Litigation
12:08PM  European stocks make little headway before the holiday, with banks in the spotlight at MarketWatch
11:13AM  U.S. hits Credit Suisse, Deutsche Bank with toxic debt penalties Reuters
Credit Suisse Group AG, together with its subsidiaries, provides various financial services worldwide. It operates through Swiss Universal Bank, International Wealth Management, Asia Pacific, Global Markets, and Investment Banking & Capital Markets segments. The company offers a range of advice and financial solutions, including structured advisory; investment advice; wealth and asset management; fixed income products and instruments; securitized products; M&A transactions; corporate sales and restructurings; divestitures; takeover defense strategies; equity and debt underwritings; equity and fixed income sales; debt and equity securities; private placements; and trading services, as well as derivative products. It also offers various banking services, such as lending, payment, capital goods leasing, syndications and structured finance, trade finance, ship and aviation finance, export finance and factoring, treasury, and foreign exchange services, as well as fund solutions and fund-linked services. In addition, the company provides global securities sales, trading and execution, prime brokerage, and investment research services; and investment solutions and services to pension funds, foundations and endowments, and individuals. It operates 447 offices and branches. The company offers its products and services to private, corporate, institutional, high-net-worth and ultra-high-net-worth individuals, small and medium-sized enterprises, governments, and institutional investors, as well as affluent and retail clients. Credit Suisse Group AG was founded in 1856 and is based in Zurich, Switzerland.